BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic steatohepatitis
1
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 45 | Download: 37
2
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
10/24/2020 2:27:20 AM | Browse: 24 | Download: 30
3
Role of betaine in liver disease-worth revisiting or has the die been cast?
10/14/2020 11:33:23 AM | Browse: 17 | Download: 59
4
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 25 | Download: 43
5
Management of nonalcoholic fatty liver disease in the Middle East
7/7/2020 2:50:53 PM | Browse: 111 | Download: 44
6
Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
6/19/2020 9:46:52 AM | Browse: 118 | Download: 129
7
Natural products that target macrophages in treating non-alcoholic steatohepatitis
5/14/2020 3:43:04 AM | Browse: 151 | Download: 149
8
L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis
2/28/2020 10:08:51 AM | Browse: 207 | Download: 200
9
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
9/7/2019 4:43:36 AM | Browse: 193 | Download: 343
10
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 316 | Download: 332
11
Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
5/28/2019 9:29:42 AM | Browse: 325 | Download: 353
12
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 317 | Download: 243
13
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 262 | Download: 176
14
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 416 | Download: 412
15
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 295 | Download: 230
16
Current status of imaging in nonalcoholic fatty liver disease
8/27/2018 12:43:23 PM | Browse: 421 | Download: 342
17
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 457 | Download: 327
18
Apoptosis and non-alcoholic fatty liver diseases
7/5/2018 1:33:43 AM | Browse: 389 | Download: 211
19
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 366 | Download: 361
20
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 369 | Download: 207
21
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 485 | Download: 271
22
Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
4/19/2018 7:56:07 AM | Browse: 398 | Download: 458
23
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 446 | Download: 303
24
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
4/11/2018 8:28:49 AM | Browse: 539 | Download: 324
25
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
1/14/2018 5:07:58 AM | Browse: 575 | Download: 270
26
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 509 | Download: 352
27
Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
8/14/2017 1:56:00 AM | Browse: 402 | Download: 437
28
Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study
7/7/2017 11:41:16 AM | Browse: 451 | Download: 283
29
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease
6/14/2017 9:25:57 AM | Browse: 513 | Download: 494
30
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
1/19/2017 11:16:00 AM | Browse: 864 | Download: 615
31
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
11/26/2016 6:56:00 PM | Browse: 493 | Download: 465
32
Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
10/26/2016 5:33:00 PM | Browse: 514 | Download: 585
33
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
10/20/2016 5:06:00 PM | Browse: 807 | Download: 473
34
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
9/30/2016 5:59:00 PM | Browse: 700 | Download: 479
35
DNA methylation of angiotensin Ⅱ receptor gene in nonalcoholic steatohepatitis-related liver fibrosis
9/28/2016 4:37:00 PM | Browse: 466 | Download: 576
36
Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014
9/26/2016 8:04:00 AM | Browse: 555 | Download: 943
37
Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis
8/25/2016 10:46:00 AM | Browse: 563 | Download: 633
38
Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
8/15/2016 10:30:00 AM | Browse: 636 | Download: 560
39
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
8/15/2016 10:30:00 AM | Browse: 992 | Download: 592
40
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
6/2/2016 3:42:00 PM | Browse: 898 | Download: 958
41
Insulin resistance in development and progression of nonalcoholic fatty liver disease
5/13/2016 2:24:00 PM | Browse: 925 | Download: 876
42
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease
3/29/2016 3:29:00 PM | Browse: 732 | Download: 1166
43
Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression
3/4/2016 7:53:00 PM | Browse: 607 | Download: 864
44
Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice
2/25/2016 7:04:00 PM | Browse: 525 | Download: 608
45
Bile acid receptors and nonalcoholic fatty liver disease
12/4/2015 3:24:00 PM | Browse: 843 | Download: 977
46
Circulating microRNAs in patients with non-alcoholic fatty liver disease
12/2/2015 12:22:00 PM | Browse: 910 | Download: 648
47
Lipid-lowering agents in the management of nonalcoholic fatty liver disease
12/2/2015 12:19:00 PM | Browse: 847 | Download: 577
48
Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease
12/2/2015 12:01:00 PM | Browse: 783 | Download: 700
49
Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico
11/3/2015 5:30:00 PM | Browse: 659 | Download: 829
50
Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma
10/19/2015 4:02:00 PM | Browse: 548 | Download: 693